Results

Total Results: 3,675 records

Showing results for "design sample size".

  1. www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-screening
    April 30, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Breast Cancer: Screening April 30, 2024 Recommendations made by the USPSTF are independent of the U.S. government. They should not be constru…
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/TYPA75a_t7HaJeDhWqCJ9n
    August 13, 2019 - Two reviewers independently assessed the methodological quality of eli- gible studies using design-specific … sizes were small and estimates imprecise. … Across 45 prospective cohort studies on diagnostic accuracy, mean sample size was 500 (range, 42-24 854 … Mean sample size was 326 (range, 21-1000), mean age was 29.2 years (range, 26.3-32.6), and mean BMI was … Concept and design: Pillay, Donovan, Chou, Hartling.
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
    January 01, 2017 - postoperative (discharge from postanesthesia care to up to 10 days postsurgery) agent for pain (KQ6) Design … Extraction and Synthesis We extracted data from included studies into templates that recorded study design … Individual Studies in Systematic Reviews of Health Care Interventions11) appropriate to each study design
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
    October 01, 2012 - and specificity.50 For the other Key Questions, we combined studies in a meta-analysis if the study design … methodological quality was assessed using different tools depending on the Key Question and study design … find a statistically significant difference in pregnancy outcomes appears more dependent on study design … Differences may have also resulted due to study design: in the ACHOIS trial, participants did not receive
  5. S66 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
    October 01, 2007 - Strict selection criteria limit generalization of results13; most trials are of short duration3; and samplesize constraints limit their ability to identify infrequent adverse effects.12–14 Fi- nally, the experimental … Using a large cohort of Medicaid enrollees with RA, we applied a new user design to compare measurements
  6. effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-e-1_0.xlsx
    January 01, 2020 - Author, Year Year KQ 1 BVM vs SGA KQ 2 BVM vs ETI KQ 3 SGA vs ETI KQ4 Variations of Single Airway Study Design … Emergency Type Prehospital Provider Study Level P+P155rovider Group Mode of Transport Eligibility Criteria SampleSize % Female Age Mean (SD) Race/Ethnicity Funding Source Risk of Bias Arima, 2014 2014 0 0 0 ETI
  7. integrationacademy.ahrq.gov/sites/default/files/2025-07/MOUD_Playbook_Environmental_Scan_2025.pdf
    January 01, 2025 - a Barrier to Care............................................................................. 33 Design … oud-low-threshold-treatment Delivering Medications for Opioid Use Disorder in Primary Care: Environmental Scan 34 Design … Crisis Refocus the Playbook to Promote Low-Threshold Care Address Stigma as a Barrier to Care Design
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
    January 01, 2010 - Adults With Type 1 Diabetes Study Design. … Adults With Type 2 Diabetes Study Design. … Pregnant Women With Pre-Existing Type 1 Diabetes Study Design. … Study Design. … All studies targeted type 1 diabetes and most studies had small sample sizes. Outcomes.
  9. integrationacademy.ahrq.gov/sites/default/files/2025-06/Innovations%20in%20Behavioral%20Health%20Integration_Transcript.docx
    January 01, 2025 - the Moud treatment. 71 00:15:59.750 --> 00:16:26.929 Anna Ratzliff (she/her): So this is the basic design … In other words, because the design of the trial was an intent to treat design.
  10. hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V22%20Definitions%20Manual.pdf
    April 01, 2006 - ___APS-Def_Public.book 2 3 2 1 W h i t n e y A v e n u e • H a m d e n , C T 0 6 5 1 8 • 1 - 8 0 0 - 9 9 9 - 3 7 4 7 D e f i n i t i o n s M a n u a l APS-DRGs ALL-PAYER SEVERITY-ADJUSTED DRG (APS-DRGS®) ASSIGNMENT FOR PUBLIC USE VERSION 22 ® PUB 4.5.2006 COPYRIGHT PAGE Copyright © 2006 HSS Inc. A…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
    January 01, 2010 - SCIT: 8 Excluded 1,626 Reasons for Exclusion at Article Review Level* • Abstract only: 45 • Study design … The majority of studies had a moderate risk of bias due to the design choices that were made. … Most of the studies had small sample sizes; so, relevant statistical information on continuous outcomes … The RCTs should be conducted with attention to the design elements that reduce bias, such as clear … How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an
  12. www.uspreventiveservicestaskforce.org/uspstf/recommendation/hiv-sexually-transmitted-diseases-behavioral-counseling-1996
    January 01, 1996 - number of persons injecting drugs or the frequency of drug use. 65 , 66 Due to difficulties in study design
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - comparisons were included for the outcome of neuropathy, but studies were at high risk for bias, with low samplesizes and poorly defined outcomes. … Evidence Table Author, Year Intervention Comparator(s) Study Design N, Population Duration Primary … comparisons were included for the outcome of neuropathy, but studies were at high risk for bias, with low samplesizes and poorly defined outcomes.
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/B_Ae7DdLL7DNauBLXC-ptu
    June 01, 2003 - Staff of the funding agency and members of the USPSTF contributed to the study design, reviewed draft … One RCT with a crossover design showed that 6 weeks of therapy with clomipramine (a tricyclic antidepressant
  15. effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
    March 29, 2016 - Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Early Diagnosis, Prevention, and Treatment of Clostridium difficile: Update Draft review available for public comment from April 20, 2015…
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zmvjborz6pkcGVzgcP5nCw
    September 30, 2024 - Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement Screening for Breast Cancer US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force Summary of Recommendations See the Summary of Recommendations figure. IMPORTANCE Among all US women, breas…
  17. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
    April 30, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Breast Cancer: Screening April 30, 2024 Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…
  18. www.ahrq.gov/research/findings/nhqrdr/chartbooks/healthyliving/healthyliving-slides.html
    April 01, 2018 - Numbers of measures differ across groups because of sample size limitations. … Number of measures differs across groups because of sample size limitations.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
    October 01, 2017 - Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking White Paper Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking Research White Paper Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking Prepared for: Agency …
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
    March 18, 2014 - Study design is a key issue here, with unique models of care emerging at different institutions. … The section on design characteristics should summarize the level of the intervention and comparison … GQ3, excellent points about the lack of research done, the heterogeneity of models, and the study design … Efforts to design and evaluate survivorship care models must have assessment of outcomes/endpoints